Cite
HARVARD Citation
Calvo Ferrandiz, A. et al. (n.d.). 470PSafety run-in evaluation of the phase I trial of trifluridine/tipiracil (FTD/TPI) in combination with oxaliplatin and a monoclonal antibody (bevacizumab or nivolumab) in patients (pts) with metastatic colorectal cancer (mCRC). Annals of oncology. p. . [Online].